Related Experiment Video
Updated: Dec 31, 2025
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Metabolomic profiling in children with inflammatory bowel disease
Aleksandra Filimoniuk1, Urszula Daniluk1, Paulina Samczuk2
1Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, Bialystok, Poland.
This study reviews metabolomics in pediatric inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn
Area of Science:
- Gastroenterology
- Immunology
- Metabolomics
Background:
- Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD), have complex causes involving genetics, environment, and gut microbes.
- Immune system and gut microbiota interactions influence metabolic pathways, leading to altered metabolite profiles in IBD patients.
- Metabolomics offers a way to analyze these metabolites and potentially identify disease biomarkers.
Purpose of the Study:
- To review and synthesize current knowledge on metabolomics in pediatric patients diagnosed with UC or CD.
- To address the gap in research focusing on pediatric IBD, as most existing studies involve adults on treatment.
Main Methods:
- Systematic literature review of published studies.
- Analysis of metabolomic profiling in pediatric patients with UC and CD.
- Focus on identifying metabolite alterations specific to pediatric IBD.
Main Results:
- Existing research indicates altered metabolite profiles in IBD patients.
- Most studies on IBD metabolomics have focused on adult populations, potentially confounding results due to ongoing treatments.
- Limited data exists specifically for pediatric UC and CD metabolomic profiling.
Conclusions:
- Metabolomic profiling shows promise for identifying biomarkers in pediatric IBD.
- Further research is needed to establish reliable metabolomic signatures for pediatric UC and CD.
- Understanding metabolomic changes in children with IBD is crucial for accurate diagnosis and treatment.
More Related Videos
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...